OP-047 Initial Experience on the Use of Novel Oral Anticoagulants (NOAC) in Adults with Congenital Heart Disease
Objective Nowadays, most patients with Congenital Heart Disease survive to adulthood. Numerous adults with Congenital Heart Disease (ACHD) are prone to thromboembolic events. A study from our institution showed that…